The Latest Cardiac and Vascular News
Collaboration Delivers Robust eLearning Curriculum to Healthcare Schools and Hospitals to Elevate the Standard of Peripheral IV Access and Care BETHLEHEM, Pa., Sept. 29, 2022 /PRNewswire/ — Today B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, together with the Association for Vascular Access (AVA), announced the launch of The Fundamentals of Peripheral IV […]
Following Receipt of FDA Breakthrough Device Designation, Market Leading Global Organizations Strengthen their Cooperation to Navigate U.S. Regulatory Pathway BETHLEHEM, Pa., March 31, 2021 /PRNewswire/ — B. Braun Interventional Systems Inc. (BIS) announced today that they will collaborate with Infraredx, a Nipro Company, to accelerate the U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) clinical trial for the […]
BETHLEHEM, Pa., Aug. 29, 2019 (GLOBE NEWSWIRE) — B. Braun Interventional Systems Inc. (BIS), a company dedicated to providing innovative solutions in the field of congenital and structural interventional cardiology, today announced it has signed an exclusive U.S. distribution agreement with Nano4imaging for their EmeryGlide™ guidewire. The EmeryGlide MR conditional guidewire is the latest cutting-edge […]
BETHLEHEM, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) — B. Braun Interventional Systems Inc. (BIS) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the SeQuent Please ReX drug-coated PTCA balloon catheter for the treatment of coronary in-stent restenosis (ISR). SeQuent Please ReX is the latest generation coronary drug-coated […]
BETHLEHEM, Pa., June 08, 2018 (GLOBE NEWSWIRE) — B. Braun Medical Inc. will feature products that help fight healthcare-associated infections – and will support (through an unrestricted educational grant to Saxe Healthcare Communications) a continuing education (CE) accredited presentation about a new technique that can be used to proactively address transmission of pathogenic organisms in […]
